Revenue grew 24% year-on-year to SAR 1.6 billion, with patient volumes up 33% and gross profit up 31%. Margin improvement and expansion are targeted through operational efficiencies and contract renegotiations, while receivables and insurance claim rejections remain key risks.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.